Pascual-García, Mónica http://orcid.org/0000-0002-9768-0641
Bonfill-Teixidor, Ester
Planas-Rigol, Ester
Rubio-Perez, Carlota
Iurlaro, Raffaella
Arias, Alexandra
Cuartas, Isabel
Sala-Hojman, Ada
Escudero, Laura http://orcid.org/0000-0001-7385-673X
Martínez-Ricarte, Francisco
Huber-Ruano, Isabel
Nuciforo, Paolo http://orcid.org/0000-0003-1380-0990
Pedrosa, Leire
Marques, Carolina http://orcid.org/0000-0002-8308-5630
Braña, Irene
Garralda, Elena
Vieito, María
Squatrito, Massimo http://orcid.org/0000-0002-4593-3790
Pineda, Estela
Graus, Francesc
Espejo, Carmen http://orcid.org/0000-0001-9949-5901
Sahuquillo, Juan http://orcid.org/0000-0003-0713-5875
Tabernero, Josep http://orcid.org/0000-0002-2495-8139
Seoane, Joan
Article History
Received: 28 March 2019
Accepted: 8 May 2019
First Online: 11 June 2019
Competing interests
: J.S. is a founder of Mosaic Biomedicals and share holder of Northern Biologics. J.S. received grant/research support from Mosaic Biomedicals, Northern Biologics and Roche/Glycart. J.T. reports scientific consultancy role for Array Biopharma, AstraZeneca, Bayer, BeiGene, Boehringer Ingelheim, Chugai, Genentech Inc., Genmab A/S, Halozyme, Imugene Limited, Inflection Biosciences Limited, Ipsen, Kura Oncology, Lilly, MSD, Menarini, Merck Serono, Merrimack, Merus, Molecular Partners, Novartis, Peptomyc, Pfizer, Pharmacyclics, ProteoDesign SL, Rafael Pharmaceuticals, F. Hoffmann–La Roche Ltd., Sanofi, SeaGen, Seattle Genetics, Servier, Symphogen, Taiho, VCN Biosciences, Biocartis, Foundation Medicine, HalioDX SAS and Roche Diagnostics. E.P. reports scientific consultancy role for Celgene. E.P. reports scientific consultancy role for Celgene. E.G. received grant/research support from Novartis. E.G. reports scientific consultancy role for Roche/Genentech, Hoffmann La Roche, Ellipses Pharma, Neomed Therapeutics, Boehringer Ingelheim, Janssen Globlas Services, AstraZeneca. I.B. reports scientific consultancy role for Orion Pharma. P.N. reports scientific consultancy role for Bayer, Novartis and Merck Sharp and Dohme. The remaining authors declare no competing interests.